共 20 条
[1]
Populationpharm_acokineticsofcontinuousinfusionceftazidime. FrameB,FaccaB,NicolauD,etal. Clinical Pharmacokinetics . 1999
[2]
Vancomycin pharmacokineticsinapatientpopulation:effectsof age,gender,andbodyweight. DucharmeM,SlaughterR,EdwardsD. Therapeutic Drug Monitoring . 1994
[3]
Genderandageas factorsintheinhibitionofrenalclearanceofamantad_inebyquinineandquinidine. GaudryS,SitarD,SmythD,etal. Clinical Pharmacology and Therapeutics . 1993
[4]
Thepopulation pharmacokineticsoflong-termmethotrexateinrheu_matoidarthritis. GodfreyC,SweeneyK,MillerK,etal. BrJClinPharmacol . 1998
[5]
Digoxinpopulati_onpharmacokineticsfromroutineclinicaldata:rolesof patientcharacteristicsforestimatingdosingregiments. YukawaE,MineH,HiguchiS,etal. JPharmPharmacol . 1992
[6]
Factorsinfluencingelimination anddistributionoffleroxacin:metaanalysisofindivid ualdatafrom10pharmacokineticstudies. ReignerBG,WelkerH. Antimic_robAgentsChemother . 1996
[7]
Thecon_tributionofintestinalandhepaticCYP3Atotheinter actionbetweenmedazolamandclarithromycin. GorskiJ,JomesD,Haehner-DanielsB,etal. Clinical Pharmacology and Therapeutics . 1998
[8]
Pharmacokineti_cs,pharmacodynamics,andsafetyofinhaledcyclospor_inA (AD1628)aftersingleandrepeatedadministra tioninhealthymaleandfemalesubjectsandasthmatic patients. RohatagiS,CalicF,HardingN,etal. JClinPharmacol . 2000
[9]
Gender-specificeffectsonverapamilpharmacokineticsand pharmacodynamicsinhumans. Krecic-ShepardM,BarnasC,SlimkoJ,etal. JClinPharmacol . 2000
[10]
Clinicalpharmacokineticsof alprazolam:therapeuticimplications. GreenblattD,WrightC. ClinPharma cokinet . 1993